Attached files
file | filename |
---|---|
EX-99.1 - Inotiv, Inc. | v193761_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): August 13, 2010
BIOANALYTICAL
SYSTEMS, INC.
|
(Exact
name of registrant as specified in its
charter)
|
Indiana
|
0-23357
|
35-1345024
|
||
(State
or other jurisdiction of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification
No.)
|
2701
KENT AVENUE
WEST
LAFAYETTE, INDIANA
|
47906-1382
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (765) 463-4527
The
information provided in Item 2.02 and Item 9.01 of this Form 8-K is being
furnished and shall not be deemed "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that Section. The information in Item 2.02 and Item 9.01 of this
Form 8-K shall not be incorporated by reference into any registration statement
or other document pursuant to the Securities Act of 1933, as
amended.
Item 2.02. Results of Operations and Financial
Condition.
On August
13, 2010, Bioanalytical Systems, Inc. issued a press release announcing results
for the first nine months of fiscal 2010, ending June 30, 2010. The full text of
the press release is furnished as Exhibit 99.1 to this Form 8-K and is
incorporated herein by reference.
Item 9.01. Financial Statements and
Exhibits.
(a) Not
applicable.
(b) Not
applicable.
(c) Not
applicable.
(d) Exhibits
99.1
Bioanalytical Systems, Inc. press release, issued August 13, 2010.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Bioanalytical
Systems, Inc.
|
||
Date:
August 13, 2010
|
By:
|
/s/ Michael
R. Cox
|
Michael
R. Cox
|
||
Vice
President, Finance and Administration,
Chief
Financial Officer and
Treasurer
|
Exhibit
Index
Exhibit
No. Description
99.1 Bioanalytical
Systems, Inc. press release, issued August 13, 2010.